PLEASANTON, Calif. — Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, acquired Trinean today. Trinean’s DropSense systems measure protein, DNA and RNA concentration in biologics and genomics samples. This is Unchained Labs’ 5th acquisition in just over 2 years. DropSense96 is the only system out there that […]

Acquisition of Daylight Solutions Expands Italy-based Leonardo’s US Presence and Infrared Laser Capabilities FOSTER CITY, CA – Mooreland Partners,the leading independent investment bank providing M&A and private capital advisory services to the global technology industry, today announced that it acted as the exclusive financial advisor to Daylight Solutions on its $150 million acquisition by Leonardo DRS, the US subsidiary of Leonardo Finmeccanica […]

– Adds to Repligen a leader in bioprocess filtration with expertise in hollow fiber technology – Strengthens flagship XCell™ ATF product line with an extensive filtration consumables portfolio – Diversifies markets beyond monoclonal antibody manufacturing into vaccine, recombinant protein and gene therapy production – Expands global commercial organization and adds direct sales in the US, […]

Innova CEO and CSO Dr. Nick Gee becomes Chief Technical Officer of SYGNIS Madrid, Spain, Heidelberg, Germany, and Cambridge, UK: Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, has announced it has been fully acquired by Sygnis AG, for EUR 8 million in cash and 3.5 million in shares. Innova’s range of […]

AlsaChim brand becomes a 100% part of the Shimadzu Group / Clients benefit from one-stop solutions of complex analytical systems /   Shimadzu, one of the world leaders in analytical instrumentation, has joined forces with the France-based AlsaChim company, an independent contract research and development organization. AlsaChim specializes in stable isotope-labelled compounds, metabolites and pharmaceutical […]

Accelerates revenue and earnings growth by adding leading positions in autoimmune and allergy diagnostics and strengthens leadership in China and other emerging markets Significant opportunity to leverage technologies, strong market positions and synergistic commercial activities to deliver better solutions across an expanding customer base Highly compelling deployment of capital, significantly advancing PerkinElmer’s strategic priorities and […]

Asslar. The Executive Board and the Supervisory Board of Pfeiffer Vacuum Technology AG (“Pfeiffer Vacuum”) have taken note of the outcome of the public takeover offer of Pangea GmbH, a company owned by Busch SE (“Busch Group”), now that the offer period has ended. The exceedingly low acceptance rate of just approximately 0.17% confirms that […]

Additional two-week acceptance period expected to commence on 9 June 2017 and expire on 22 June 2017 Maulburg. Pangea GmbH, a wholly owned subsidiary of Busch SE, today announced the initial results of the voluntary public tender offer for the shares of Pfeiffer Vacuum Technology AG (ISIN: DE0006916604). The initial acceptance period expired at midnight […]